IPO PULLED: Animal-rights activists in China are claiming a rare victory after a company that raises bears to extract bile from them withdrew its application for an initial public offering.
BACKLASH: The planned IPO of Fujian Guizhentang Pharmaceutical had caused outrage on social media and sparked online petitions from activists who say the practice is painful for the bears — bile is extracted from live, caged bears via catheters or holes in their bodies — and the tonics produced of debatable medicinal validity.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
